Synthesis of recommendations from 25 countries and 31 oncology societies: how to navigate through COVID-19 labyrinth
Authors
Kamposioras, KonstantinosMauri, D.
Papadimitriou, K.
Anthoney, A.
Hindi, N.
Petricevic, B.
Dambrosio, M.
Valachis, A.
Kountourakis, P.
Kopecky, J.
Kuhar, C. G.
Popovic, L.
Chilingirova, N. P.
Zarkavelis, G.
de Mello, R. A.
Plavetic, N. D.
Christopoulos, C.
Mostert, B.
Goffin, J. R.
Tzachanis, D.
Saraireh, H. H.
Ma, F.
Pavese, I.
Tolia, M.
Affiliation
Department of Medical Oncology, The Christie NHS Foundation Trust, Manchester,Issue Date
2020
Metadata
Show full item recordAbstract
Introduction: Pandemic COVID-19 is an unexpected challenge for the oncological community, indicating potential detrimental effects on cancer patients. Our aim was to summarize the converging key points providing a general guidance in order to support decision making, pertaining to the oncologic care in the middle of a global outbreak. Methods: We did an international online search in twenty five countries that have managed a surge in cancer patient numbers. We collected the recommendations from thirty one medical oncology societies. Results: By synthesizing guidelines for a) oncology service delivery adjustments, b) general and specific treatment adaptations, and c) discrepancies from guidelines comparison, we present a clinical synopsis with the forty more crucial statements. A Covid-19 risk stratification base was also created in order to obtain a quick, objective patient assessment and a risk-benefit evaluation on a case-by-case basis. Conclusions: In an attempt to face these complex needs and due to limited understanding of COVID-19, a variability of recommendations based on general epidemiological and infectious disease principles rather than definite cancer-related evidence has evolved. Additionally, the absence of an effective treatment or vaccine requires the development of cancer management guidance, capitalizing on comprehensive COVID-19 oncology experience globally.Citation
Kamposioras K, Mauri D, Papadimitriou K, Anthoney A, Hindi N, Petricevic B, et al. Synthesis of Recommendations From 25 Countries and 31 Oncology Societies: How to Navigate Through Covid-19 Labyrinth. Front Oncol. 2020;10:575148.Journal
Frontiers in OncologyDOI
10.3389/fonc.2020.575148PubMed ID
33330049Additional Links
https://dx.doi.org/10.3389/fonc.2020.575148Type
ArticleLanguage
enae974a485f413a2113503eed53cd6c53
10.3389/fonc.2020.575148
Scopus Count
Collections
Related articles
- The future of Cochrane Neonatal.
- Authors: Soll RF, Ovelman C, McGuire W
- Issue date: 2020 Nov
- Systematic review of international guidelines for head and neck oncology management in COVID-19 patients.
- Authors: Gascon L, Fournier I, Chiesa-Estomba C, Russo G, Fakhry N, Lechien JR, Burnell L, Vergez S, Metwaly O, Capasso P, Ayad T
- Issue date: 2022 Feb
- Evidence-Based Risk Mitigation and Stratification During COVID-19 for Return to Interventional Pain Practice: American Society of Interventional Pain Physicians (ASIPP) Guidelines.
- Authors: Shah S, Diwan S, Soin A, Rajput K, Mahajan A, Manchikanti L, Kaye AD, Hirsch JA, Gharibo C
- Issue date: 2020 Aug
- ESMO management and treatment adapted recommendations in the COVID-19 era: gynaecological malignancies.
- Authors: Colombo I, Zaccarelli E, Del Grande M, Tomao F, Multinu F, Betella I, Ledermann JA, Gonzalez-Martin A, Sessa C, Colombo N
- Issue date: 2020 Jul
- Adapting care for older cancer patients during the COVID-19 pandemic: Recommendations from the International Society of Geriatric Oncology (SIOG) COVID-19 Working Group.
- Authors: Battisti NML, Mislang AR, Cooper L, O'Donovan A, Audisio RA, Cheung KL, Sarrió RG, Stauder R, Soto-Perez-de-Celis E, Jaklitsch M, Williams GR, O'Hanlon S, Alam M, Cairo C, Colloca G, Gil LA Jr, Sattar S, Kantilal K, Russo C, Lichtman SM, Brain E, Kanesvaran R, Wildiers H
- Issue date: 2020 Nov